Reduction in postprandial glucose excursion and prolongation of satiety: possible explanation of the long-term effects of whole grain salba (salvia hispanica l.)
European Journal of Clinical Nutrition (2010), 1–3& 2010 Macmillan Publishers Limited All rights reserved 0954-3007/10 $32.00
Reduction in postprandial glucose excursion andprolongation of satiety: possible explanation ofthe long-term effects of whole grain Salba(Salvia Hispanica L.)
V Vuksan1,2,3,4,5, AL Jenkins1, AG Dias1,3, AS Lee1,3, E Jovanovski1, AL Rogovik1 and A Hanna4,5
1Clinical Nutrition and Risk Factor Modification Centre, St Michael’s Hospital, Toronto, Ontario, Canada; 2Keenan Research Center ofthe Li Ka Shing Knowledge Institute, St Michael’s Hospital, Toronto, Ontario, Canada; 3Department of Nutritional Sciences, Faculty ofMedicine, University of Toronto, Toronto, Ontario, Canada; 4Department of Medicine, Faculty of Medicine, University of Toronto,Toronto, Ontario, Canada and 5Division of Endocrinology and Metabolism, St Michael’s Hospital, Toronto, Ontario, Canada
Despite strong correlations linking whole-grain consumption to reductions in heart disease, the physiological mechanismsinvolved remain ambiguous. We assessed whether Salba (Salvia Hispanica L.) whole grain reduces postprandial glycemia inhealthy subjects, as a possible explanation for its cardioprotective effects observed in individuals with diabetes. The study usedacute, randomized, double-blind, controlled design in which 11 healthy individuals (6 males and 5 females; body mass index22.3±2.8 kg/m2) received 0, 7, 15 or 24 g of Salba baked into white bread. Capillary samples and appetite ratings werecollected over 2 h after consumption. A dose-response reduction in postprandial glycemia (P ¼ 0.002, r2 ¼ 0.203) was observedwith all three doses of Salba, significantly decreasing incremental areas under the curve (iAUCs) and time point-specific bloodglucose (Po0.05). Appetite ratings were decreased at 60 min after high, 90 min after high and intermediate and at 120 min afterall treatments (Po0.05). Decrease in postprandial glycemia provides a potential explanation for improvements in bloodpressure, coagulation and inflammatory markers previously observed after 12-week Salba supplementation in type II diabetes.
European Journal of Clinical Nutrition advance online publication, 20 January 2010;
Keywords: Salba; whole grain; glycemia; appetite
glycemia. To analyze this hypothesis we studied the acuteeffect of escalating doses of Salba on glycemia and satiety.
Given the importance of consuming whole grains as acardioprotective measure, there is increasing interest in theireffects on type II diabetes. We have previously shown thatconsumption of 37 g/day of the oily grain Salvia Hispanica L.
(Salba) improves cardiovascular risk factors by reducingblood pressure, inflammatory and coagulation markers in
A total of 11 healthy individuals (6 males and 5 females; age
subjects with well-controlled type II diabetes
30±3.6 years; body mass index 22.2±1.3 kg/m2) partici-
Mechanistically, this may occur through Salba’s
pated in this study. Subjects with gastrointestinal/metabolic
ability to trigger a favorable biochemical cascade that leads
diseases or who were taking potential postprandial meta-
to the observed changes through reductions in postprandial
bolism-altering supplements were excluded. The study wasapproved by the research ethics board of St Michael’sHospital. Written informed consent was obtained from all
Correspondence: Dr V Vuksan, Clinical Nutrition and Risk Factor Modification
Centre, St Michael’s Hospital, 70 Richmond Street East, Suite 100, Toronto,
A double-blind, placebo-controlled, randomized, crossover
design was used. Participants attended the clinic on five
E-mail: Received 28 July 2009; revised 24 October 2009; accepted 6 November 2009
mornings, separated by at least 48 h, after a 10- to 12-h fast.
Finger-prick capillary blood and subjective appetite ratings
eat right now?). Appetite rating was calculated from these
were collected in the fasting state and at 15, 30, 45, 60, 90
Salba is a brand name used to describe two registered white
varieties, Sahi Alba 911 and 912, that are the result of
selective breeding from the black grain Salvia Hispanica L.
Incremental areas under the curve (iAUCs) for blood
(also popularly called Chia) by the Peruvian company
glucose and for the average appetite ratings were calculated
Agrisalba S.A. Salba has a nutrient profile that is approxi-
mately 20% higher than generic or regular Chia. In addition,
Statistical analysis was performed using NCSS-2000
the nutrient profile of Salba is highly standardized, which
(NCSS, Kaysville, UT, USA). Results were expressed as
allows for a high degree of reproducibility. Experimental
mean±s.d. and significance was set at Po0.05. Statistical
meals contained 50 g available carbohydrate with addition of
analysis was conducted after a comparison of the sampling
0, 7, 15 or 24 g of Salba (Salba Smart Natural Products,
distribution to a normal distribution (Shapiro–Wilk and
Denver, CO, USA), which was ground by micro-slicing rather
Kolmogorov–Smirnov tests). Pearson’s correlations and
than the crushing method (to reduce rancidity) and baked
linear regression analysis were used to determine dose-
into white bread in a Black & Decker All-In-One Pro
response relationships for glucose and appetite iAUCs.
Breadmaker (The Black & Decker Corporation, Towson,
Two-way analysis of variance was performed with the
MD, USA) according to standard recipes. Energy value and
glucose values and appetite scores at each time point with
macronutrient compositions of test and control breads are
post hoc assessment using the Neuman–Keuls method to
shown in Control white bread was consumed twice
Capillary blood samples were analyzed using the glucose-
oxidase method (YSI 2300 STAT Analyzer, Yellow Springs,
OH, USA). Satiety was assessed using four questions withopposing statements at each end of 100 mm visual analog
Compared with control, the percentage of reductions in
scale (How full do you feel? How strong is your desire to eat?
mean iAUCs for blood glucose were 41, 28 and 21% after
How hungry do you feel? How much do you think you could
high, intermediate and low Salba doses, respectively (Po0. 05;Furthermore, significantly lower blood glucoselevels were observed after the high dose at 30, 45 and 60 min,
Energy value and macronutrient compositions of test and
intermediate at 60 min and low dose at 45 min (Po0.05)
compared with control. Linear regression analysis showed
glucose iAUCs to be significantly associated with the Salba
dose (P ¼ 0.002; r2 ¼ 0.203; r ¼ 0.45).
Appetite ratings were decreased when compared with
control at 60, 90 and 120 min after the high dose, at 90
and 120 min after the intermediate and at 120 min after
the low dose (Po0.05; Incremental AUC appetite
ratings decreased by 63, 58 and 41% after high, intermediate
and low doses but this did not reach significance. Significant
Incremental changes and iAUCs for postprandial blood glucose and appetite after high, intermediate, and low dose, and control treatments
Abbreviations: iAUC, incremental area under the curve; Int., intermediate.
aData are mean±s.d. IAUCs are expressed in min mol/l for blood glucose and in min mm for appetite.
bSignificantly different from the control group (Po0.05).
Salba reduces postprandial glycemiaV Vuksan et al
correlation between incremental blood glucose and incre-
mental appetite values was observed (Po0.001; r ¼ 0.32).
The authors declare no conflict of interest.
These preliminary data suggest that ingestion of escalatingdoses of Salba attenuate postprandial glycemia in a dose-
Salba Smart Natural Products, Denver, CO, USA, provided
dependent manner in healthy subjects. On average, each
Salba grain. The results were presented as an abstract at
gram of Salba baked in the white bread reduced postprandial
glycemia by 2% compared with the control. Reductions in
2008;22:305.6), supported by an unrestricted travel grant
postprandial glycemia observed after Salba are not dissimilar
received from Salba Corporation S.A, Buenos Aires, Argentina.
to those observed with acarbose (despite different mechanisms of action. Interestingly, acar-bose showed similar long-term effects on blood pressure,
Blundell JE, Rogers PJ (1991). Hunger, hedonics, and the control of
satiation and satiety. In: Friedman MI, Tordoff MG, Kare MR (eds).
supporting the hypothesis that long-term benefits
Chemical Senses, Vol IV. Appetite and Nutrition. Marcel Dekker:
observed with both may be achieved through attenuating
postprandial glycemia. Furthermore, both may affect signals
Brouns F, Bjorck I, Frayn KN, Gibbs AL, Lang V, Slama G et al. (2005).
Glycaemic index methodology. Nutr Res Rev 18, 145–171.
of satiety, as showed by the prolongation of satiety observed
Ceriello A, Taboga C, Tonutti L, Giacomello R, Stel L, Motz E et al.
with Salba and an increase in satiety gut hormones by
(1996). Post-meal coagulation activation in diabetes mellitus: the
effect of acarbose. Diabetologia 39, 469–473.
Despite small sample size, this number has been shown to
Chiasson JL (2006). Acarbose for the prevention of diabetes,
hypertension, and cardiovascular disease in subjects with im-
provide a reasonable degree of power and precision when
paired glucose tolerance: the Study to Prevent Non-Insulin-
Dependent Diabetes Mellitus (STOP-NIDDM) Trial. Endocr Pract
Similarly, although this study included only healthy indivi-
duals it may nevertheless apply to individuals with diabetes,
Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M
(2003). Acarbose treatment and the risk of cardiovascular disease
as hyperglycemia is an independent predictor of future
and hypertension in patients with impaired glucose tolerance: the
cardiovascular events in both healthy and diabetic indivi-
STOP-NIDDM trial. JAMA 290, 486–494.
Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999). The relationship
The simultaneous attenuation of both postprandial glyce-
between glucose and incident cardiovascular events. A metare-gression analysis of published data from 20 studies of 95 783
mia and prolongation of satiety by Salba can be explained
individuals followed for 12.4 years. Diabetes Care 22, 233–240.
by the reduction in the rate of nutrient delivery from the
Gentilcore D, Bryant B, Wishart JM, Morris HA, Horowitz M, Jones KL
stomach to the small intestine, and concurrently providing
(2005). Acarbose attenuates the hypotensive response to sucrose
continuous and more extended signals to the gut receptors,
and slows gastric emptying in the elderly. Am J Med 118, 1289.
Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP et al. (2006).
affecting after-meal satiety levels and ingestion sensory
Activation of oxidative stress by acute glucose fluctuations
compared with sustained chronic hyperglycemia in patients with
calcium, magnesium and antioxidant capacity of Salba are
type 2 diabetes. JAMA 295, 1681–1687.
likely to be the main triggers of these effects.
O’Keefe JH, Bell DS (2007). Postprandial hyperglycemia/hyperlipide-
mia (postprandial dysmetabolism) is a cardiovascular risk factor.
The importance of controlling postprandial glycemia is
supported by the observation that postprandial glucose
O’Keefe JH, Gheewala NM, O’Keefe JO (2008). Dietary strategies
excursion independently activates homeostasis of thrombo-
for improving post-prandial glucose, lipids, inflammation, and
tic-prone conditions, mediated by transient overproduction
cardiovascular health. J Am Coll Cardiol 51, 249–255.
Read N, French S, Cunningham K (1994). The role of the gut in
regulating food intake in man. Nutr Rev 52, 1–10.
radicals induce a biochemical cascade resulting in increased
Shimabukuro M, Higa N, Chinen I, Yamakawa K, Takasu N (2006).
inflammation, hypercoaguability and endothelial dysfunc-
Effects of a single administration of acarbose on postprandial glucose
tion that favors vasoconstriction and elevation of blood
excursion and endothelial dysfunction in type 2 diabetic patients: arandomized crossover study. J Clin Endocrinol Metab 91, 837–842.
pressure, leading to diabetes and early cardiovascular disease
Vuksan V, Whitham D, Sievenpiper JL, Jenkins AL, Rogovik AL,
Bazinet RP et al. (2007). Supplementation of conventional therapy
with the novel grain Salba (Salvia hispanica L.) improves major
glycemia and the increase in satiety observed in this study
and emerging cardiovascular risk factors in type 2 diabetes: resultsof a randomized controlled trial. Diabetes Care 30, 2804–2810.
can at least in part offer explanation for reductions in blood
Wolever TM, Jenkins DJ, Jenkins AL, Josse RG (1991). The glycemic
pressure, inflammatory and coagulation factors observed in
index: methodology and clinical implications. Am J Clin Nutr 54,
http://www.facebook.com/groups/10085964554 Acid Reflux/GORD Information Sheet Updated 28 July 2012 What is Acid Reflux? Acid reflux – or heart burn happens when acid from the stomach enters the oesophagus – the bit that connects the mouth to the stomach. This can cause a burning sensation – and in the long term can cause oesophagitis -damage the oesophagus. Persistent reflu
relate patient outcomes with any particular nurse(s) in this study. 1. Aiken LH, Clarke SP, Cheung RB, Sloane DM, Silber JH. Educational levels of hospital nurses and surgical patient mortality. JAMA . 2003;290:1617-1623. In a hospital categorized as having a high proportion of bacca-laureate-prepared nurses, it could well have been the RN with To the Editor: Dr Aiken and colleagues1 presen